APP and Alzheimer disease: These data led to the formulation of the Ca2+ overload hypothesis for AD, in which a higher ER [Ca2+] causes both altered APP processing, with an accumulation of Aβ toxic peptides, and deregulated kinase activity, leading to tau hyper-phosphorylation and eventually to a Ca2+-dependent neuronal death [111].